A Study of Maribavir in Chinese Adults With Cytomegalovirus (CMV) Infections

Clinical trial NCT06439342 · RECRUITING

Trial details

NCT number: NCT06439342
Sponsor: Takeda
Status: RECRUITING
Phase: Phase 3
Study type: INTERVENTIONAL

Cytomegalovirus (CMV)

Start date: 2024-12-16
Primary completion: 2026-12-31
Enrollment: 20

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.